Horizon Therapeutics plc HZNP announced that it has completed enrollment in the phase IV study evaluating its marketed drug, Tepezza (teprotumumab-trbw), for the treatment of thyroid eye disease (TED) ...
Which TED Talk presenters spark the most conversation among viewers? The answer, according to a new study, is professors — though Internet celebrity is unlikely to earn them any points within their ...
Horizon Therapeutics HZNP announced positive top-line results from its phase IV study of Tepezza for the treatment of Thyroid Eye Disease (TED) in adult patients with chronic/low clinical activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results